Citigroup’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Sell |
30,291
-11,532
| -28% | -$59K | ﹤0.01% | 3460 |
|
|
2025
Q1 | $57.3K | Sell |
41,823
-5,169
| -11% | -$7.08K | ﹤0.01% | 4077 |
|
|
2024
Q4 | $145K | Buy |
46,992
+8,316
| +22% | +$25.7K | ﹤0.01% | 3794 |
|
|
2024
Q3 | $298K | Buy |
38,676
+16,611
| +75% | +$128K | ﹤0.01% | 3328 |
|
|
2024
Q2 | $189K | Sell |
22,065
-169,368
| -88% | -$1.45M | ﹤0.01% | 3183 |
|
|
2024
Q1 | $1.52M | Buy |
191,433
+183,270
| +2,245% | +$1.46M | ﹤0.01% | 2044 |
|
|
2023
Q4 | $80.8K | Buy |
8,163
+6,945
| +570% | +$68.8K | ﹤0.01% | 3545 |
|
|
2023
Q3 | $13.7K | Sell |
1,218
-14,910
| -92% | -$168K | ﹤0.01% | 3775 |
|
|
2023
Q2 | $53.5K | Buy |
16,128
+7,937
| +97% | +$26.4K | ﹤0.01% | 3933 |
|
|
2023
Q1 | $32.4K | Sell |
8,191
-2,152
| -21% | -$8.5K | ﹤0.01% | 3735 |
|
|
2022
Q4 | $75K | Sell |
10,343
-1,449
| -12% | -$10.5K | ﹤0.01% | 3450 |
|
|
2022
Q3 | $43K | Sell |
11,792
-1,752
| -13% | -$6.39K | ﹤0.01% | 3745 |
|
|
2022
Q2 | $61K | Sell |
13,544
-23,165
| -63% | -$104K | ﹤0.01% | 3780 |
|
|
2022
Q1 | $278K | Buy |
36,709
+4,267
| +13% | +$32.3K | ﹤0.01% | 3216 |
|
|
2021
Q4 | $355K | Buy |
32,442
+29,273
| +924% | +$320K | ﹤0.01% | 3277 |
|
|
2021
Q3 | $41K | Buy |
+3,169
| New | +$41K | ﹤0.01% | 4097 |
|